Nava Siegelmann-Danieli

6PUBLICATIONS
6CO-AUTHORS
Models of care and place of birthCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersDisease surveillanceCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 11, 2024
Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting.

Sarah Sharman Moser, Lior Apter, Idit Livnat

|Nov 15, 2023
Publicly Funded Cancer Care: Are Adjuvant Therapies Prioritized Over Treatment of Metastatic Cancer? The Israeli Experience.

Ariel Hammerman, Carmil Azran, Yael Topol

|Oct 16, 2023
Whole exome germline sequencing in early-onset prostate cancer patients: Genomic findings and clinical outcomes.

Nava Siegelmann-Danieli, Victoria Neiman, Avital Bareket-Samish

|Dec 10, 2021
Hormone-Replacement Therapy and Its Association with Breast Cancer Subtypes: A Large Retrospective Cohort Study.

Vered Rosenberg, Avital Bareket-Samish, Gabriel Chodick

|May 26, 2021
Real-world study of PD-L1 testing patterns and treatment distribution in patients with metastatic non-small-cell lung cancer in Israel.

Sarah Sharman Moser, Lior Apter, Ashwini Arunachalam

|Sep 16, 2017
Does levonorgestrel-releasing intrauterine system increase breast cancer risk in peri-menopausal women? An HMO perspective.

Nava Siegelmann-Danieli, Itzhak Katzir, Janet Vesterman Landes

Pageof 1

Frequent Collaborators

1 joint publications

Sarah Sharman Moser

1 joint publications

Ashwini Arunachalam

1 joint publications

Thomas Burke

1 joint publications

Varda Shalev